Atea Pharmaceuticals, Inc. (AVIR)
5.96
+0.09
(+1.53%)
USD |
NASDAQ |
Apr 07, 16:00
5.96
0.00 (0.00%)
After-Hours: 18:36
Atea Pharmaceuticals EPS Diluted (Quarterly) : -0.5743 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Oramed Pharmaceuticals, Inc. | 0.2274 |
| Aclaris Therapeutics, Inc. | -0.1614 |
| PMV Pharmaceuticals, Inc. | -0.3385 |
| Instil Bio, Inc. | -1.208 |
| Alumis, Inc. | -0.8875 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -44.87M |
| Total Expenses (Quarterly) | 44.87M |
| Enterprise Value | 166.69M |
| Earnings Yield | -32.14% |
| Normalized Earnings Yield | -32.14 |